Senores-new-logo-2023-01Senores-new-logo-2023-01Senores-new-logo-2023-01Senores-new-logo-2023-01
  • About Us
    • About Senores Group
    • Milestone
  • Manufacturing Capabilities
    • Formulations
    • API
  • Products
    • Formulations
    • API
  • Partnership
  • R&D Pipeline
    • Formulations
    • API
  • Career
  • Contact

Media

Media Coverage

MAY 2022

Dr. Reddy's and Senores Pharmaceuticals, Inc. launches Ketorolac Tromethamine Tablets (Source: Bloomberg)

MAR 2022

Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. launches Butalbital, Acetaminophen and Caffeine Capsules (Source: Yahoo Finance)

JAN 2022

Senores Pharmaceuticals, Inc. launches Mexiletine Hydrochloride Capsules (Source: Market Insider)

OCT 2021

Cintex Services, LLC and Senores Pharmaceuticals, Inc. launches Chlorzoxazone Tablets (Source: BioSpace)

NOV 2020

Jubilant Pharma Ltd. and Aavis Pharmaceuticals launches Hydroxychloroquine Sulfate Tablets (Source: Seeking Alpha)

Press Release

MAY 2022

Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. launches Ketorolac Tromethamine Tablets in the U.S. market

MAR 2022

Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. launches Butalbital, Acetaminophen and Caffeine Capsules  in the U.S. market

JAN 2022

Senores Pharmaceuticals, Inc. launches Mexiletine Hydrochloride Capsules with one of the top 5 generic pharmaceutical companies in the U.S. market

OCT 2021

Cintex Services, LLC and Senores Pharmaceuticals, Inc. launches Chlorzoxazone Tablets in the U.S. market

NOV 2020

Jubilant Pharma Ltd. and Aavis Pharmaceuticals Inc. launches Hydroxychloroquine Sulfate Tablets in the U.S. market

Useful Links

  • About Us
  • Manufacturing Capabilities
  • Products
  • Partnership
  • R&D Pipeline
  • ADR
  • Media
  • Contact

Disclaimer

All the information present on Senores Pharmaceuticals website is not applicable to all the countries across the world. The purpose of this website is to provide information about Senores Pharmaceuticals' products and services. Any information present on the website shouldn't be misused or construed to spread or promote any of the products in the countries where are disapproved or prohibited.

© 2023 Senores Pharmaceuticals | All Rights Reserved.